President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

List includes medications for diabetes, cancer, arthritis, and more ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

CMS has announced that the new cycle of drug price negotiations by Medicare will include big-name drugs for diabetes and HIV/AIDS, as well as Botox injections. 1,2 The 15 high-cost prescription drugs ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

Fifteen prescription medications will be the focus of federal price negotiations that could lower prices for Medicare patients.

Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...

Eli Lilly and Co. (NYSE:LLY) released topline results from SURPASS-CVOT, a head-to-head Phase 3 cardiovascular outcomes trial comparing Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, to ...

By Michael Erman and Deena Beasley Jan 27 (Reuters) - The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug ...